Sunshine Biopharma, Inc. (SBFM) short interest & options flow
NASDAQSBFM (Sunshine Biopharma) has seen one of the most dramatic lending-market dislocations in its history. In five trading days, the cost to borrow exploded from 17% to 561%. Short interest jumped 603% in a week to 13.6% of free float. A week ago, the borrow market was wide open. Availability stood at 1,295% — roughly 13 shares available for every…
SBFM cost to borrow explodes to 561.1% — up from 17.4% last week as short sellers pile in ahead of earnings.
- Market cap
- $533131
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026
Latest signals on SBFM
- Cost to Borrow
SBFM cost to borrow explodes to 561.1% — up from 17.4% last week as short sellers pile in ahead of earnings.
- Short Interest
SBFM short interest surges 603% in one week to 13.6% of float; cost to borrow explodes to 561%, highest recorded.
- Utilization
SBFM utilization hits 97.46%, highest level in 52 weeks — shares available to borrow plunge 99.7% in one week to just 3.27%.
SBFM news and analysis
RSSNo long-form analysis yet for SBFM. Pulse alerts and the live data picture are available on ORTEX.
Open SBFM on ORTEX →Want the live picture for SBFM?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SBFM — free to start on ORTEX.
Sign up for free →Open SBFM on ORTEX